SOR-CART-MM-001 Study: A Phase I, Open-Label, Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Study of Safety and Efficacy of CAR2 Anti-CD38 A2 CAR-T Cells in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
| Title: | SOR-CART-MM-001 Study: A Phase I, Open-Label, Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Study of Safety and Efficacy of CAR2 Anti-CD38 A2 CAR-T Cells in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) |
|---|---|
| Authors: | Stadtmauer, Edward A., Elghawy, Omar, Roberts, Todd F., Madduri, Deepu, Ailawadhi, Sikander, Royal, Mike, Yan, Ying |
| Source: | In Blood 2 November 2023 142 Supplement 1:6851-6851 |
| Database: | ScienceDirect |
| ISSN: | 00064971 |
|---|---|
| DOI: | 10.1182/blood-2023-178636 |
| Published in: | Blood |
| Language: | English |